To investigate the antiproliferative effects of our KIF18A inhibitors more broadly, we conducted a PRISM (profiling relative inhibition simultaneously in mixtures) screen with AM-1882 on a large panel of DNA-barcoded cancer cell lines, using a 5-d cell growth assay40,41. This evidence concerns the gene KIF18A and cancer.